Serum N-Glycan Preparation Using Temperature-Gradient Denaturation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for analyzing serum glycoproteins face challenges such as precipitation during denaturation, inhibition by free sugars, and inefficient sample preparation for deep glycomics analysis, particularly in large-scale processing.

Innovation Solution

A method involving amine-functionalized magnetic beads and a temperature gradient denaturation process is used to capture and denature glycoproteins, followed by enzyme-mediated glycan release and labeling, which minimizes precipitation and removes inhibitory sugars, enabling high-sensitivity analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If traditional denaturation methods are used with larger than 10 μL of serum samples, then sufficient analyte amount is achieved for analysis, but precipitation occurs during the denaturation step

Engineering Contradiction:
Improvesample volumeVSAvoidprecipitation-free denaturation
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The serum sample is divided into multiple aliquots and processed in parallel using multiple reaction tubes, allowing each tube to contain a smaller volume (≤10 μL) that can be completely denatured without precipitation, while the total analyzed volume can be scaled up by increasing the number of tubes

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The problem is solved by transitioning from a single-tube bulk denaturation approach to a multi-tube distributed denaturation approach, adding the dimension of parallel processing to achieve both sufficient total analyte amount and complete denaturation without precipitation in each individual tube

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Productivity

If endoglycosidase digestion is performed in the presence of free sugars, then glycan release is achieved, but monosaccharides and low DP sugars act as inhibitors

Engineering Contradiction:
Improveglycan release efficiencyVSAvoidinhibition by free sugars
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

Free sugars are removed from the serum sample prior to endoglycosidase digestion through precipitation with cold ethanol or other suitable methods, eliminating the inhibitory substances before the enzymatic reaction begins, thereby allowing complete and efficient glycan release without inhibition

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The removal of free sugars is performed as a preliminary step before the endoglycosidase digestion, preventing the harmful inhibitory effect from occurring during the enzymatic reaction and ensuring optimal productivity throughout the digestion process

Inventive Principle:
Principle #10Preliminary action

3Quantity of substance

If sample volume is increased to achieve deep glycomics analysis, then sufficient analyte concentration is obtained, but precipitation occurs during denaturation

Engineering Contradiction:
Improveanalyte amountVSAvoiddenaturation completeness
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

Large volume samples are segmented into multiple smaller aliquots for parallel processing, ensuring complete denaturation in each aliquot while maintaining sufficient total analyte amount across all samples for deep glycomics analysis

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The denaturation parameters are optimized for small volume samples (≤10 μL), including temperature, time, and reagent concentrations, allowing complete denaturation without precipitation in each aliquot while the total analyte amount is scaled up through parallel processing of multiple aliquots

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the preparation of serum samples with up to 50 μL volume and 30 mg/mL protein concentration without precipitation, enhancing the sensitivity and efficiency of capillary electrophoresis and CE-ESI-MS analysis, particularly in negative ionization mode.

Implementation Method 1

mixing said serum sample with amine-functionalized magnetic beads so as to capture glycoproteins contained in said serum sample onto said magnetic beads

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

denaturing the glycoproteins by mixing a denaturation solution with said magnetic beads and applying an increasing temperature gradient over a period of time

Methodology Applied
Scientific EffectTemperature gradient: Temperature Gradient

Implementation Method 3

releasing the glycan portion from the peptide portion in the glycoprotein captured on the magnetic bead using an enzyme to form a released glycan portion

Methodology Applied
Scientific EffectEnzyme: Enzyme

Data Source

PatentUS12510547B2Sample preparation by temperature gradient denaturation and scale-up for deep n-glycomic analysis of serum for capillary electrophoresis and CE-ESI-MS
Publication Date: 2025.12.30 DH TECH DEVMENT PTE
  • US12510547B2 patent drawing
  • US12510547B2 patent drawing
  • US12510547B2 patent drawing

AI summary

A sample preparation workflow to facilitate deep N-glycomics analysis of human serum by capillary electrophoresis with laser induced fluorescence (CE-LIF) detection accommodates the higher sample concentration requirement of electrospray ionization mass spectrometry connected to capillary electrophoresis (CE-ESI-MS). A temperature gradient denaturing protocol is applied on amine functionalized magnetic bead partitioned glycoproteins to avoid precipitation. This also results in the free sugar content of the serum being significantly decreased which allows PNGase F mediated release of the N-linked carbohydrates. The liberated oligosaccharides were tagged with aminopyrene-trisulfonate, utilizing a modified evaporative labeling protocol. This workflow provides appropriate amounts of material for example for use in CE-ESI-MS analysis in negative ionization mode.